Clarence Patrick Machado Insider Trading Transactions
Get free email notifications about insider trading for Clarence Patrick Machado.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clarence Patrick Machado. Clarence Patrick Machado is Director in MEDIVATION, INC. ($MDVN) and Sr. Vice President and CFO in MEDIVATION, INC. ($MDVN) and Director in CHIMERIX INC ($CMRX) and Director in SCYNEXIS INC ($SCYX) and Director in ENDOCYTE INC ($ECYT) and Director in INOTEK PHARMACEUTICALS CORP ($ITEK) and 10% Owner in Arbutus Biopharma Corp ($TKMR) and Director in Principia Biopharma Inc. ($PRNB) and Director in Adverum Biotechnologies, Inc. ($ADVM) and Director in Turning Point Therapeutics, Inc. ($TPTX) and 10% Owner in Axovant Sciences Ltd. ($AXON) and Director in Axovant Sciences Ltd. ($AXON) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and Director in Arcus Biosciences, Inc. ($RCUS) and 10% Owner in Urovant Sciences Ltd. ($UROV).
Latest Insider Trading Transactions of Clarence Patrick Machado
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, TKMR, RCUS, CMRX, ECYT, MDVN, MYOV, PRNB, RCKT, SCYX, AXON, TPTX, UROV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 04 2021 | TPTX | Turning Point Ther ... | Machado Patrick | Director | Option Exercise | A | 65.64 | 8,500 | 557,940 | 8,500 | |
May 14 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 3.70 | 12,500 | 46,250 | 12,500 | |
May 14 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
Mar 24 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Buy | P | 9.92 | 10,000 | 99,196 | 88,182 | 78.2 K to 88.2 K (+12.79 %) |
Jan 19 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Buy | P | 11.52 | 10,000 | 115,174 | 78,182 | 68.2 K to 78.2 K (+14.67 %) |
Sep 28 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | D | 31.77 | 20,475 | 650,491 | 0 | |
Jun 25 2020 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
Jun 17 2020 | TPTX | Turning Point Ther ... | Machado Patrick | Director | Option Exercise | A | 65.39 | 8,500 | 555,815 | 8,500 | |
Jun 15 2020 | CMRX | CHIMERIX INC | Machado Patrick | Director | Option Exercise | A | 2.85 | 35,000 | 99,750 | 35,000 | |
Jun 08 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | A | 62.66 | 10,240 | 641,638 | 10,240 | |
Jun 08 2020 | RCUS | Arcus Biosciences, ... | Machado Patrick | Director | Option Exercise | A | 30.05 | 14,000 | 420,700 | 14,000 | |
Jun 08 2020 | RCUS | Arcus Biosciences, ... | Machado Patrick | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Jan 03 2020 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 11.52 | 15,000 | 172,800 | 15,000 | |
Jan 03 2020 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 11.52 | 15,000 | 172,800 | 15,000 | |
Dec 12 2019 | RCUS | Arcus Biosciences, ... | Machado Patrick | Director | Option Exercise | A | 8.55 | 50,000 | 427,500 | 50,000 | |
Aug 02 2019 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 13.41 | 45,000 | 603,450 | 45,000 | |
Jun 24 2019 | CMRX | CHIMERIX INC | Machado Patrick | Director | Option Exercise | A | 3.37 | 21,000 | 70,770 | 21,000 | |
Jun 19 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | A | 31.77 | 10,240 | 325,325 | 10,240 | |
Jun 11 2019 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | A | 31.77 | 20,475 | 650,491 | 20,475 | |
Jun 11 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | MYOV | Myovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
Mar 19 2019 | AXON | Axovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 1.50 | 6,666,667 | 10,000,001 | 105,952,381 | 99.3 M to 106 M (+6.71 %) |
Jan 04 2019 | SCYX | SCYNEXIS INC | Machado Patrick | Director | Option Exercise | A | 0.54 | 22,500 | 12,242 | 22,500 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | Machado Patrick | Director | Option Exercise | D | 10.81 | 19,500 | 210,795 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | Machado Patrick | Director | Option Exercise | D | 4.20 | 22,500 | 94,500 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | Machado Patrick | Director | Sell | D | 24.00 | 3,300 | 79,200 | 0 | 3.3 K to 0 (-100.00 %) |
Dec 21 2018 | ECYT | ENDOCYTE INC | Machado Patrick | Director | Sell | D | 24.00 | 2,500 | 60,000 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 21 2018 | ECYT | ENDOCYTE INC | Machado Patrick | Director | Sell | D | 24.00 | 1,250 | 30,000 | 0 | 1.3 K to 0 (-100.00 %) |
Dec 20 2018 | AXON | Axovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 1.00 | 10,000,000 | 10,000,000 | 99,285,714 | 89.3 M to 99.3 M (+11.20 %) |
Oct 03 2018 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Jun 21 2018 | CMRX | CHIMERIX INC | Machado Patrick | Director | Option Exercise | A | 4.82 | 21,000 | 101,220 | 21,000 | |
Jun 15 2018 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 6.25 | 35,000 | 218,750 | 35,000 | |
Jun 07 2018 | AXON | Axovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 1.75 | 14,285,714 | 25,000,000 | 89,285,714 | 75 M to 89.3 M (+19.05 %) |
May 04 2018 | ECYT | ENDOCYTE INC | Machado Patrick | Director | Option Exercise | A | 10.81 | 19,500 | 210,795 | 19,500 | |
May 04 2018 | ECYT | ENDOCYTE INC | Machado Patrick | Director | Grant | A | 0.00 | 3,300 | 0 | 7,050 | 3.8 K to 7.1 K (+88.00 %) |
Apr 04 2018 | MYOV | Myovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
Mar 01 2018 | ECYT | ENDOCYTE INC | Machado Patrick | Director | Option Exercise | A | 4.20 | 22,500 | 94,500 | 22,500 | |
Mar 01 2018 | ECYT | ENDOCYTE INC | Machado Patrick | Director | Grant | A | 0.00 | 3,750 | 0 | 3,750 | 0 to 3.8 K |
Feb 20 2018 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 6.40 | 10,000 | 64,000 | 10,000 | |
Jan 16 2018 | TKMR | Arbutus Biopharma ... | Machado Patrick | 10% Owner | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
Jan 04 2018 | SCYX | SCYNEXIS INC | Machado Patrick | Director | Option Exercise | A | 2.28 | 19,989 | 45,575 | 19,989 | |
Oct 17 2017 | TKMR | Arbutus Biopharma ... | Machado Patrick | 10% Owner | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
Jul 19 2017 | AXON | Axovant Sciences L ... | Machado Patrick | Director | Option Exercise | A | 23.67 | 70,000 | 1,656,900 | 70,000 | |
Jun 29 2017 | CMRX | CHIMERIX INC | Machado Patrick | Director | Option Exercise | A | 5.53 | 21,000 | 116,130 | 21,000 | |
Jun 21 2017 | ITEK | INOTEK PHARMACEUTI ... | Machado Patrick | Director | Option Exercise | A | 1.80 | 45,000 | 81,000 | 45,000 | |
Jun 14 2017 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 2.75 | 33,602 | 92,406 | 33,602 | |
Jun 14 2017 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Grant | A | 0.00 | 22,727 | 0 | 68,182 | 45.5 K to 68.2 K (+50.00 %) |
Mar 16 2017 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 2.75 | 64,767 | 178,109 | 64,767 | |
Mar 16 2017 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Grant | A | 0.00 | 45,455 | 0 | 45,455 | 0 to 45.5 K |
Jan 05 2017 | SCYX | SCYNEXIS INC | Machado Patrick | Director | Option Exercise | A | 3.40 | 14,499 | 49,297 | 14,499 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Machado Patrick | Director | Option Exercise | D | 12.20 | 222,800 | 2,717,603 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Machado Patrick | Director | Option Exercise | D | 58.89 | 6,228 | 366,767 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Machado Patrick | Director | Option Exercise | D | 55.45 | 6,284 | 348,448 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Machado Patrick | Director | Option Exercise | D | 38.89 | 9,584 | 372,686 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Machado Patrick | Director | Option Exercise | D | 27.43 | 90,000 | 2,468,700 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Machado Patrick | Director | Option Exercise | D | 3.37 | 33,336 | 112,259 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Machado Patrick | Director | Option Exercise | D | 8.64 | 264,000 | 2,280,960 | 0 | |
Sep 30 2016 | MDVN | MEDIVATION, INC. | Machado Patrick | Director | Sell | U | 0.00 | 70,792 | 0 | 0 | 70.8 K to 0 (-100.00 %) |
Sep 16 2016 | SCYX | SCYNEXIS INC | Machado Patrick | Director | Buy | P | 2.94 | 40,000 | 117,600 | 60,000 | 20 K to 60 K (+200.00 %) |
Aug 18 2016 | ITEK | INOTEK PHARMACEUTI ... | Machado Patrick | Director | Option Exercise | A | 6.91 | 24,000 | 165,840 | 24,000 | |
Jun 28 2016 | CMRX | CHIMERIX INC | Machado Clarence Patrick | Director | Option Exercise | A | 3.73 | 9,000 | 33,570 | 9,000 | |
Jun 28 2016 | SCYX | SCYNEXIS INC | Machado Clarence Patrick | Director | Option Exercise | P | 3.00 | 9,000 | 27,000 | 9,000 | |
Jun 28 2016 | SCYX | SCYNEXIS INC | Machado Clarence Patrick | Director | Buy | P | 2.39 | 20,000 | 47,800 | 20,000 | 0 to 20 K |
Jun 23 2016 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Option Exercise | A | 58.89 | 6,228 | 366,767 | 6,228 | |
Jun 23 2016 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Grant | A | 0.00 | 2,972 | 0 | 70,792 | 67.8 K to 70.8 K (+4.38 %) |
Jun 06 2016 | SCYX | SCYNEXIS INC | Machado Clarence Patrick | Director | Option Exercise | A | 3.98 | 8,800 | 35,024 | 8,800 | |
Jan 21 2016 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Option Exercise | M | 3.37 | 75,000 | 252,563 | 33,336 | |
Jan 21 2016 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 39.19 | 6,950 | 272,371 | 66,156 | 73.1 K to 66.2 K (-9.51 %) |
Jan 21 2016 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 38.62 | 7,942 | 306,720 | 73,106 | 81 K to 73.1 K (-9.80 %) |
Jan 21 2016 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 37.50 | 23,087 | 865,763 | 81,048 | 104.1 K to 81 K (-22.17 %) |
Jan 21 2016 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 36.62 | 37,021 | 1,355,709 | 104,135 | 141.2 K to 104.1 K (-26.23 %) |
Jan 21 2016 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Buy | M | 3.37 | 75,000 | 252,525 | 141,156 | 66.2 K to 141.2 K (+113.37 %) |
Dec 30 2015 | CMRX | CHIMERIX INC | Machado Clarence Patrick | Director | Buy | P | 7.08 | 10,000 | 70,846 | 10,000 | 0 to 10 K |
Sep 28 2015 | SCYX | SCYNEXIS INC | Machado Clarence Patrick | Director | Option Exercise | A | 6.89 | 11,700 | 80,613 | 11,700 | |
Sep 28 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Option Exercise | M | 4.69 | 71,980 | 337,766 | 0 | |
Sep 28 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 43.92 | 17,680 | 776,506 | 66,156 | 83.8 K to 66.2 K (-21.09 %) |
Sep 28 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 42.68 | 20,464 | 873,404 | 83,836 | 104.3 K to 83.8 K (-19.62 %) |
Sep 28 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 41.63 | 22,236 | 925,685 | 104,300 | 126.5 K to 104.3 K (-17.57 %) |
Sep 28 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 40.82 | 11,600 | 473,512 | 125,536 | 137.1 K to 125.5 K (-8.46 %) |
Sep 28 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Buy | M | 4.69 | 71,980 | 337,766 | 138,136 | 66.2 K to 138.1 K (+108.80 %) |
Jun 24 2015 | CMRX | CHIMERIX INC | Machado Clarence Patrick | Director | Option Exercise | A | 45.15 | 9,000 | 406,350 | 9,000 | |
Jun 18 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Option Exercise | A | 110.90 | 3,142 | 348,448 | 3,142 | |
Jun 18 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Grant | A | 0.00 | 1,578 | 0 | 33,078 | 31.5 K to 33.1 K (+5.01 %) |
Jun 08 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Option Exercise | M | 9.39 | 36,000 | 337,860 | 35,990 | |
Jun 08 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 120.04 | 300 | 36,012 | 31,500 | 31.8 K to 31.5 K (-0.94 %) |
Jun 08 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 119.06 | 9,600 | 1,142,976 | 31,800 | 41.4 K to 31.8 K (-23.19 %) |
Jun 08 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 118.38 | 6,600 | 781,308 | 41,400 | 48 K to 41.4 K (-13.75 %) |
Jun 08 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 117.10 | 2,900 | 339,590 | 48,000 | 50.9 K to 48 K (-5.70 %) |
Jun 08 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Sell | S | 116.12 | 16,600 | 1,927,592 | 50,900 | 67.5 K to 50.9 K (-24.59 %) |
Jun 08 2015 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Director | Buy | M | 9.39 | 36,000 | 337,860 | 67,500 | 31.5 K to 67.5 K (+114.29 %) |
Dec 21 2004 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Sr. Vice President ... | Option Exercise | P | 1.55 | 2,839 | 4,400 | 2,839 | |
Dec 21 2004 | MDVN | MEDIVATION, INC. | Machado Clarence Patrick | Sr. Vice President ... | Option Exercise | P | 0.00 | 24,587 | 0 | 24,587 |
Page: 1